-
RAPIDLY EVOLVING TREATMENT LANDSCAPE IN MULTIPLE MYELOMA - LEVERAGING A LIVING SYSTEMATIC LITERATURE REVIEW (SLR)
Mar 18, 2026, 21:38 PM -
INCORPORATING ENVIRONMENTAL IMPACT INTO HEALTH TECHNOLOGY ASSESSMENT: A CASE STUDY IN INHALERS
Mar 18, 2026, 21:38 PM -
HEALTH UTILITY SCORES ACROSS MAJOR CANCER TYPES BY STAGE AND TREATMENT PHASE
Mar 18, 2026, 21:38 PM -
FAST, ACCURATE, RELIABLE: PROSPECTIVE FOLLOW-UP ASSESSMENT OF THE SUPERDEDUPER MODULE IN LASER AI
Mar 18, 2026, 21:38 PM -
PREFERENCES FOR ADOPTING A MOBILE HEALTH APP: A BEST-WORST SCALING AND DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
SELF-REPORTED MARIJUANA USE, PAIN LEVELS, AND OPIOID USE AMONG ADULT CANCER SURVIVORS IN ARKANSAS
Mar 18, 2026, 21:38 PM -
PEMBROLIZUMAB ALONE VERSUS CHEMO-IMMUNOTHERAPY IN METASTATIC NSCLC: A 2024 MEDICARE-BASED MARKOV COST-EFFECTIVENESS ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF NARCOLEPSY TYPE 1 IN THE US
Mar 18, 2026, 21:38 PM -
EXTENSION OF AGENT BASED MODELING IN CHINA’S NATIONAL VOLUME BASED DRUG PROCUREMENT: BIDDING SIMULATION AND POLICY IMPLICATIONS
Mar 18, 2026, 21:38 PM -
TRANSFORMING DISEASE PREVENTION THROUGH INNOVATIVE INVESTMENT MODELS: DEVELOPMENT OF A TYPOLOGY AND TOOLKIT TO SUPPORT SUSTAINABLE PREVENTION FINANCING
Mar 18, 2026, 21:38 PM -
THE ROAD AHEAD: ARE U.S. PAYER POLICIES KEEPING PACE WITH RAPID INNOVATION IN ALZHEIMER'S DISEASE DIAGNOSTIC TESTING?
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF SAVOLITINIB-OSIMERTINIB IN ADVANCED NON-SQUAMOUS NSCLC WITH MET AMPLIFICATION FOLLOWING EGFR-TKI RESISTANCE IN CHINA
Mar 18, 2026, 21:38 PM -
ALIGNING INNOVATION, IMPLEMENTATION, PATIENT VOICE, INSTITUTIONAL TIMELINES, AND CONTINUITY IN UHC-ALIGNED POPULATION SCREENING
Mar 18, 2026, 21:38 PM -
ASSOCIATIONS OF STRUCTURAL POSITION AND HIV TESTING WITH GUIDELINE-CONCORDANT CERVICAL CANCER SCREENING AMONG U.S. WOMEN AT HIGH RISK OF HIV INFECTION
Mar 18, 2026, 21:38 PM -
BEYOND QALYS: ALTERNATIVE COST-EFFECTIVENESS MEASURES IN ICER REPORTS FROM 2019 TO 2025
Mar 18, 2026, 21:38 PM -
A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE
Mar 18, 2026, 21:38 PM -
FROM JOINT CLINICAL ASSESSMENT TO NATIONAL HTA: SIMILARITIES AND DIVERGENCES ACROSS THE EU-MEMBER STATES
Mar 18, 2026, 21:38 PM -
PHARMACY BUDGET IMPACT OF EXPANDING MEDICARE COVERAGE FOR GLP-1 RECEPTOR AGONISTS IN THE TREATMENT OF OBESITY UNDER ALTERNATIVE PRICING SCENARIOS
Mar 18, 2026, 21:38 PM -
PATIENT DESCRIPTIONS OF IMPROVED ABILITY TO SELF-REGULATE BLOOD SUGAR LEVELS IN A PHASE 3 TRIAL OF DTX401 FOR GLYCOGEN STORAGE DISEASE TYPE IA
Mar 18, 2026, 21:38 PM -
THIRTY YEARS OF THE ECHO MODEL: A BIBLIOMETRIC ANALYSIS OF ITS GLOBAL INFLUENCE ON HEALTH ECONOMICS AND OUTCOMES RESEARCH
Mar 18, 2026, 21:38 PM
